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Two Escherichia coli isolates which were isolated from the urine of patients in state hospitals in 
KwaZulu-Natal, South Africa were investigated to determine the sequence of the TEM -lactamases 
responsible for their resistance to -lactamase inhibitors. The isolates were subjected to MIC 
determinations, iso-electric focusing analysis, plasmid analysis, polymerase chain reaction (PCR) for 
the detection of -lactamase genes and sequencing of the blaTEM. Analysis of the nucleotide sequences 
revealed the presence of two novel TEM -lactamases, TEM-145 and TEM-146 which had the R244H 
mutation. Mutations at position 244 have been previously reported in other inhibitor-resistant TEMs 
(IRTs).   
 





-lactam antibiotics are the most frequently prescribed 
antimicrobial agents in clinical practice (Canica et al., 
1998; Pitout et al., 2005). In response, bacteria have 
acquired resistance to these antibiotics. In parallel with 
molecular modifications introduced to overcome this 
resistance, bacteria have modified their resistance 
mechanisms. The most significant mechanism of 
resistance to the -lactam antimicrobial agents is the 
production of -lactamase enzymes (Blásquez et al., 
2000; Morris et al., 2003). In members of the family 
Enterobacteriaceae, the most prevalent mechanism of 
resistance to broad-spectrum -lactams is detoxification 
of the drugs by plasmid-mediated enzymes that are 
variants of TEM and SHV penicillinases. The TEM-
derived extended-spectrum -lactamases (ESBLs) or 
inhibitor-resistant -lactamases differ from the parental 
TEM-1 and TEM-2 penicillinases by various combinations 
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Amoxicillin/clavulanate is a -lactam--lactamase inhi-
bitor combination that has antimicrobial activity against a 
wide variety of organisms. Escherichia coli, one of the 
most common pathogens, is usually susceptible to amo-
xicillin/clavulanate (Kaye et al., 2004). However, resis-
tance has begun to emerge. The use of -lactam--lacta-
mase inhibitor combinations has selected mutant deriva-
tives of the TEM and SHV families of class A -lactama-
ses that have become relatively resistant to inactivation 
by -lactamase inactivators and thereby confer resistan-
ce to these combinations (Vakulenko et al., 1998). Resis-
tance to amoxicillin/clavulanate appeared first in E. coli 
isolates and then in other species of enterobacteria 
(Speldooren et al., 1998). Resistance to the combination 
of amoxicillin and clavulanate in strains of E. coli may be 
due to a numbers of factors, four of which are enzymatic, 
viz., hyper-production of class C chromosomal -lactama-
se, hyper-production of plasmid-mediated TEM-1 or 
TEM-2, production of inhibitor-resistant TEM (IRT) and 
the production of a relatively inhibitor-resistant OXA-type 
-lactamase (Sirot et al., 1994; Speldooren et al., 1998).  
In this study we report the presence of two novel TEM 
-lactamases; TEM-145 and TEM-146 which were found 
in two E. coli clinical isolates. 
 




Table 1. Primers used in PCR studies. 
 
Primer Sequence Purpose of primer Reference 
TEM1(F) 5’-ATGAGTATTCAACATTTCCGTG-3’ Amp Essack et al., 2001 
TEM2(R) 5’-TTACCAATGCTTAATCAGTGAG-3’ Amp/Seq Essack et al., 2001 
TEM3(R) 5’-TTCTGTGACTGGTGAGTACT-3’ Seq Essack et al., 2001 
TEM4(R) 5’-GAGTAAGTAGTTCGCCAGTT-3’ Seq Essack et al., 2001 
TEM5(F) 5’-CTGCAGCAATGGCAACAAC-3’ Amp/Seq Designed for this study 
 








E. coli NWE11 and E. coli PMM40 were isolated from the urine samples 
of patients in hospitals in KwaZulu-Natal, South Africa in 2000. The 
identity of the strains as E. coli was confirmed using the API20E 
identification system (bioMérieux sa, Lyon, France). E. coli ATCC 25922 
and E. coli NCTC 50192 served as the control for determination of 
minimum inhibitory concentrations (MIC) and plasmid size analysis 
respectively. E. coli CF204 was used as a TEM-3 positive control. 
 
 
Antibiotic susceptibility testing 
 
Susceptibility testing was undertaken using the Kirby Bauer disc diffu-
sion method according to CLSI (formerly NCCLS) guidelines. The 
following antibiotics were used: ampicillin, ampicillin/sulbactam, amoxi-
cillin/clavulanate, ticarcillin, piperacillin, piperacillin/tazobactam, cepha-
lotin, cefuroxime-parenteral, cefoxitin, ceftriaxone, cefotaxime, ceftazi-
dime, cefepime, meropenem and aztreonam (Mast Diagnostics, Mer-
seyside, UK). MIC values were extrapolated by the BIOMIC automated 
reading system and software package (Giles Scientific, New York). 
 
 
Plasmid size analysis 
 
Plasmid DNA was extracted from overnight cultures in Nutrient Broth 
(Biolab, Johannesburg, South Africa) using the alkaline lysis method 
(Kado and Liu, 1981). Plasmid sizes were calculated using computer 





The -lactamases were extracted from pure overnight cultures in 
Nutrient Broth (Biolab, Johannesburg, South Africa) by the freeze-thaw 
method (Livermore and Williams, 1996). Analytical isoelectric focusing 
(IEF) was performed in ampholine polyacrylamide gels (pH 3.5- 9.5; 
Amersham Biosciences, Uppsala, Sweden). -lactamase bands were 
detected with nitrocefin solution ( 0.05% (w/v); Oxoid, Hampshire, 
England). An isoelectric point marker pI calibration kit (4.7 to 10.6; BDH, 
England) was the standard used.  
 
 
PCR detection of blaTEM genes 
 
A suspension of colonies from an overnight culture on Nutrient Agar 
(Biolab, Johannesburg, South Africa) was made in purified water (50 l). 
Bacterial DNA was prepared by heating this suspension at 95oC for 5 
min. PCR amplifications were then performed in a Gene Amp PCR 
System (Applied Biosystems, Claifornia, USA). The primers (Inqaba 
Biotechnology, Pretoria, South Africa) used are described in Table 1. 
The amplification of blaTEM genes was carried out as described 
previously (Essack et al., 2001). PCR products (5 l) were analyzed by 
gel electrophoresis. Gels were stained with ethidium bromide and 
photographed using UV illumination. PCR products were purified and 
sequenced (Spectrumedix SCE2410 genetic analysis system, 
Spectrumedix, Pennsylvania, USA). 
 
 
Nucleotide sequence accession number 
  
The sequences obtained were analyzed using the BLAST 2.0 software 
available on the website of the National Centre for Biotechnology 
Information (http://www.ncbi.nlm.nih.gov/Blast; last accessed June 
2006). The nucleotide and amino acid sequences of TEM-145 and 
TEM-146 were deposited in GenBank and assigned the accession num-
bers DQ105528 and DQ105529, respectively. 
 
 
RESULTS AND DISCUSSION 
 
The MIC results are shown in Table 2. Both isolates were 
resistant to amoxicillin/clavulanate and ampicillin/sulbac-
tam. E. coli PMM40 was resistant to piperacillin/tazobac-
tam whilst E. coli NWE11 displayed intermediate resis-
tance to piperacillin/tazobactam. Plasmids of 129.2 kb 
and 112.2 kb and 112.1 kb were detected in E. coli 
NWE11 and E. coli PMM40, respectively. IEF analysis 
revealed two -lactamase bands for each of the isolates. 
-lactamases with iso-electric points of 6.0 and 7.8 and 
6.6 and 8.6 were detected for E. coli NWE11 and E. coli 
PMM40, respectively. PCR amplification revealed that 
both isolates harboured blaTEM genes and also the E. coli 
chromosomal AmpC gene (results not shown). 
Sequencing data identified the TEM genes as follows: E. 
coli NWE11 carried TEM-1 and TEM-146 (novel) and E. 
coli PMM40 carried TEM-1 and TEM-145 (novel). All 
isolates were also tested for the presence of SHV-, CTX- 
and plasmid-mediated CMY-genes (results not shown) 
but these were not found. The -lactamases with pI 
values of 6.0 and 6.6 could be identified as transcripts of 
TEM -lactamase genes and those with pI values of 7.8 
and 8.6 as transcripts of the E. coli chromosomal AmpC 
genes. The TEM--lactamase enzymes showed the 
following changes compared to TEM-1: TEM-145 had two 
changes; L221M and R244H, while TEM-146 had three 
changes; T114P, M182I and R244H. 
Resistance to the -lactam--lactamase inhibitor com-
binations and ESBLs in E. coli is an emerging problem 
(Kaye et al., 2004). The emergence of IRT-producing 
strains might be related to the frequent use of inhibitor-
containing formulations in hospitals and in general 
practice (Chaibi et al., 1999). 






Table 2. MICs (g/ml) of the E. coli isolates investigated in 
this study. 
 
Antibiotic E. coli PMM40 E. coli NWE11 
AMP >32 >32 
SAM >48 >48 
AMC >64 >64 
PIP >512 >512 
TZP 96 20 (I) 
CEF >128 64 
CXM 8 8 
FOX 8 8 
CRO <1 <1 
CTX <0.5 <0.5 
CAZ 4 8 
FEP <1 <1 
MEM <0.5 <0.5 
ATM 2 4 
 
Abbreviations: AMP, ampicillin; SAM, ampicillin/ sulbactam; AMC, 
amoxicillin/clavulanate; PIP, piperacillin; TZP, piperacillin/tazobac-
tam; CEF, cephalotin; CXM, cefuroxime-parenteral; FOX, 
cefoxitin; CRO, ceftriaxone; CTX, cefotaxime; CAZ, ceftazidime; 
FEP, cefepime; MEM, meropenem; ATM, aztreonam; (I) denotes 




-lactamases, has been found in only one other TEM -
lactamase, viz., TEM-57 (IRT-15). Other reported 
mutations of Arg-244 are substitutions with serine, cystei-
ne, glycine and leucine (www.lahey.org/studies/tem-
table.asp, last accessed June 2006). In the TEM-1 
enzyme, Arg-244 is located on strand 4. Its side chain 
overlaps strand 3 and thereby takes part in interactions 
with the substrate in the active site (Bret et al., 1997). 
When Arg-244 is replaced by an amino acid with a short 
side chain such as cysteine, serine or histidine, the enz-
yme-substrate interaction is modified and affinity for the 
substrate decreases. Moreover, the shorter side chains of 
these residues would be unable to activate the water 
molecule involved in the inactivation process of clavu-
lanate (Bret et al., 1997; Chaibi et al., 1999). Site-specific 
mutations induced at the active site of TEM -lactamase 
has confirmed that replacement of arginine by serine, 
cysteine or threonine leads to clavulanic acid resistance 
(Bret et al., 1997). Sulbactam and tazobactam are 
thought to use a different mechanism and are not 
dependent on the structurally conserved water molecule 
(Chaibi et al., 1999).  
The M182I found in TEM-146 -lactamase has not 
been reported before. The other substitution reported at 
this position is the substitution of a threonine for the 
methionine. The M182T mutation has been reported for 
TEM-20, TEM-32 (IRT-3), TEM-43, TEM-52, TEM-63/64, 
TEM-72, TEM-87, TEM-88, TEM92-94, TEM-106, TEM-
107, TEM-113, TEM-124, TEM-126, TEM-131, TEM-135 
and TEM-149 (www.lahey.org/studies/temtable.asp, last 
assessed  June  2006).  Residue182 which is located just  




before the -8 helix is far from the active site (Chaibi et 
al., 1999) and the M182T mutation has been found in 
several natural ESBL mutant enzymes. It has been 
shown by thermodynamic and enzymatic studies that this 
substitution does not affect -lactamase activity but acts 
as a global stabilizer. The M182T substitution restores 
the stability lost by substitutions near the active site and, 
hence, is a rescue substitution for TEM ESBL-type 
mutants (Delmas et al., 2005). The T114P mutation is the 
first report of a mutation at this position.   
IEF analysis showed that the E. coli isolates each 
produced two enzyme bands but each of the isolates 
possessed three enzymes, i.e., TEM-1, the E. coli 
chromosomal AmpC and either TEM-145 or TEM-146. 
Also, the reported pI values for most IRTs has been 5.2 
to 5.4 (Chaibi et al., 1999). A possible reason for the 
presence of only two IEF bands instead of three could be 
the minimal expression of TEM-145/TEM-146, hence two 
IEF bands. The pI values of 6.0 and 6.6 is not typical of 
an IRT. This could possibly be attributed to minimal 





The resistance of the isolates to the inhibitor combina-
tions could be attributed to the presence of TEM-145 and 
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